Evidence map›Paper›PMID 32560435›Full record

ArticlePharmaceutics2020

Working within the Design Space: Do Our Static Process Characterization Methods Suffice?

Moritz von Stosch, René Schenkendorf, Geoffroy Geldhof, Christos Varsakelis, Marco Mariti, Sandrine Dessoy, Annick Vandercammen, Alexander Pysik, Matthew Sanders

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Moritz von StoschGSK, B-1330 Rixensart, Belgium.ORCID 0000-0001-7912-7992
René SchenkendorfInstitute of Energy and Process Systems Engineering, TU Braunschweig, 38106 Braunschweig, Germany.ORCID 0000-0002-2462-8666
Geoffroy GeldhofGSK, B-1330 Rixensart, Belgium.
Christos VarsakelisGSK, B-1330 Rixensart, Belgium.ORCID 0000-0002-8297-2916
Marco MaritiGSK, B-1330 Rixensart, Belgium.
Sandrine DessoyGSK, B-1330 Rixensart, Belgium.
Annick VandercammenGSK, B-1330 Rixensart, Belgium.
Alexander PysikGSK, B-1330 Rixensart, Belgium.
Matthew SandersGSK, B-1330 Rixensart, Belgium.
GlaxoSmithKline (Belgium) · BETechnische Universität Braunschweig · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Process Analytical Technology initiative and Quality by Design paradigm have led to changes in the guidelines and views of how to develop drug manufacturing processes. On this occasion the concept of the design space, which describes the impact of process parameters and material attributes on the attributes of the product, was introduced in the ICH Q8 guideline. The way the design space is defined and can be presented for regulatory approval seems to be left to the applicants, among who at least a consensus on how to characterize the design space seems to have evolved. The large majority of design spaces described in publications seem to follow a "static" statistical experimentation and modeling approach. Given that temporal deviations in the process parameters (i.e., moving within the design space) are of a dynamic nature, static approaches might not suffice for the consideration of the implications of variations in the values of the process parameters. In this paper, different forms of design space representations are discussed and the current consensus is challenged, which in turn, establishes the need for a dynamic representation and characterization of the design space. Subsequently, selected approaches for a dynamic representation, characterization and validation which are proposed in the literature are discussed, also showcasing the opportunity to integrate the activities of process characterization, process monitoring and process control strategy development.

Indexed as

critical process parameterscritical quality attributedynamic design spacedynamic modelingflexibilityprocess analytical technologyquality by designreachability

Identifiers

PMID32560435
PMCPMC7356980
OpenAlexW3036919830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.